Last news
Kavalan Launches Distiller's Reserve No.1 and 2 In Collaboration With South Korea's Jeju Island

Kavalan Launches Distiller's Reserve No.1 and 2 In Collaboration With South Korea's Jeju Island

Exclusive expressions blend ex-Bourbon casks across Fino sherry, rum, Manzanilla and brandy casks TAIPEI, Jan. 27, 2025 /PRNewswire/ -- Kavalan Distillery is proud to unveil The Distiller's Reserve Series, an exclusive creation crafted for Jeju...

Turfan, Xinjiang: Achieving Full Coverage of Automated Remote Workstations in the Distribution Network

Turfan, Xinjiang: Achieving Full Coverage of Automated Remote Workstations in the Distribution Network

TURFAN, China, Jan. 27, 2025 /PRNewswire/ -- "After the deployment of the automated remote workstations, we observed significant improvements in equipment operation efficiency and fault handling, as well as continuous monitoring of equipment...

Dun & Bradstreet in Hong Kong Announces Strategic Relocation to Better Serve Clients

Dun & Bradstreet in Hong Kong Announces Strategic Relocation to Better Serve Clients

HONG KONG, Jan. 27, 2025 /PRNewswire/ -- Dun & Bradstreet (D&B), a leading global provider of business decisioning data and analytics, announced its official office relocation in Hong Kong SAR (HK) to Six Pacific Place, Wan Chai. The...

Colombian President Celebrates Landmark PV Project Exclusively Powered by JA Solar

Colombian President Celebrates Landmark PV Project Exclusively Powered by JA Solar

BEIJING, Jan. 27, 2025 /PRNewswire/ -- Recently, Colombian President Gustavo Petro attended a ceremony at a refinery near Cartagena, where he personally signed a JA Solar module to commemorate the successful completion of a groundbreaking PV...

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

HONG KONG, Jan. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been accepted...

Agoda Highlights Global Events to Spark Wanderlust in 2025

Agoda Highlights Global Events to Spark Wanderlust in 2025

SINGAPORE, Jan. 27, 2025 /PRNewswire/ -- Digital travel platform Agoda shares a list of five global events in 2025 that are set to captivate travelers worldwide. These occasions provide opportunities to explore diverse cultures, witness natural...

Best Travel Destinations to Go in 2025's Year of the Snake, Based on Your Chinese Zodiac

Best Travel Destinations to Go in 2025's Year of the Snake, Based on Your Chinese Zodiac

SINGAPORE, Jan. 27, 2025 /PRNewswire/ -- As the Year of the Snake approaches in 2025, it's time to take a leaf from the wisdom of the snake and align your travel plans with the stars. Using the guidance of the Chinese Zodiac and consulted by...

CARiNG Pharmacy Celebrates Consecutive Gold Triumph at the 2024 Putra Aria Brand Awards

CARiNG Pharmacy Celebrates Consecutive Gold Triumph at the 2024 Putra Aria Brand Awards

KUALA LUMPUR, Malaysia, Jan. 27, 2025 /PRNewswire/ -- CARiNG Pharmacy is thrilled to announce its back-to-back victory in securing the Gold award in the retail category at the 2024 Putra Aria Brand Awards. This recognition highlights the brand's...

menu
menu